The effects of passive smoking on the six-minute walk test in obese pediatric cases

Nazan Kaymaz1, Şule Yıldırım, Mustafa Tekin

  • 1Çanakkale Onsekiz Mart University Faculty of Medicine, Department of Pediatrics, Çanakkale, Turkey. E-ma-il: sule.yildirim@comu.edu.tr.

Insights

Second-hand smoke exposure significantly reduced the six-minute walk test (6 MWT) distance in obese children. This finding highlights potential respiratory and cardiovascular risks in this vulnerable pediatric population.

Area of Science:

  • Pediatric Pulmonology
  • Environmental Health
  • Cardiopulmonary Function

Background:

  • Obese children face increased risk of reduced cardiopulmonary function.
  • Exposure to environmental tobacco smoke is a significant health concern for children.

Purpose of the Study:

  • To investigate the impact of second-hand smoke exposure on the six-minute walk test (6 MWT) in obese, non-asthmatic children.
  • To assess the association between passive smoking and exercise capacity in pediatric obesity.

Main Methods:

  • Seventy-five obese pediatric patients (BMI >95th percentile) without comorbidities were enrolled.
  • Participants were categorized into groups based on parental-reported passive smoking exposure.
  • The six-minute walk test (6 MWT) and spirometry were performed on all subjects.

Main Results:

  • Children exposed to passive smoking (Group 1) walked a mean of 501.88 ± 62.12 meters.
  • Children not exposed to passive smoking (Group 2) walked a mean of 559.63 ± 72.93 meters.
  • A statistically significant difference (p=0.001) was observed in 6 MWT distance between the groups.

Conclusions:

  • Passive smoking negatively impacts respiratory and cardiovascular capacity in obese children.
  • The 6 MWT is a valuable tool for monitoring cardiopulmonary function in these pediatric patients.
  • Educating families about the risks of passive smoking is crucial for protecting children's health.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.3K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
1.1K